12:29 EST Grail (GRAL) up 4% to $18.84 after guidance in conference presentation Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on GRAL: Grail: Patient-reported outcomes from PATHFINDER study published in Lancet Booking initiated, Workday downgraded: Wall Street’s top analyst calls Grail initiated with an Equal Weight at Morgan Stanley Grail tests first patient for TROPION-Lung12 Phase 3 study Disclaimer & DisclosureReport an Issue